Pathophysiology of diabetic retinopathy

被引:10
作者
Funatsu, H
Yamashita, H
机构
[1] Tokyo Womens Med Univ, Ctr Diabet, Dept Ophthalmol, Shinjuku Ku, Tokyo 1628666, Japan
[2] Yamagata Univ, Sch Med, Dept Ophthalmol, Yamagata 99023, Japan
关键词
D O I
10.1358/dnp.2002.15.10.840018
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Several interacting and mutually perpetuating biochemical pathways or systems, such as the polyol pathway, nonenzymatic glycation, oxidative stress, protein kinase Cbeta and the renin-angiotensin system, may be activated as a result of sustained hyperglycemia in diabetes. These abnormally activated pathways may in turn influence several vasoactive factors and cytokines, such as vascular endothelial growth factor, interleukin-6. pigment epithelium-derived factor and endostatin, which are important in mediating the functional and structural changes of diabetic retinopathy. Intricate and interacting regulatory mechanisms involving these factors may control their ultimate ability to produce biologically significant effects. A better understanding of these factors and their interactions may assist in the development of adjuvant therapies for the treatment of diabetic retinopathy. (C) 2002 Prous Science, All rights reserved.
引用
收藏
页码:633 / 639
页数:7
相关论文
共 53 条
[1]   VASCULAR ENDOTHELIAL GROWTH-FACTOR IN OCULAR FLUID OF PATIENTS WITH DIABETIC-RETINOPATHY AND OTHER RETINAL DISORDERS [J].
AIELLO, LP ;
AVERY, RL ;
ARRIGG, PG ;
KEYT, BA ;
JAMPEL, HD ;
SHAH, ST ;
PASQUALE, LR ;
THIEME, H ;
IWAMOTO, MA ;
PARK, JE ;
NGUYEN, HV ;
AIELLO, LM ;
FERRARA, N ;
KING, GL .
NEW ENGLAND JOURNAL OF MEDICINE, 1994, 331 (22) :1480-1487
[2]   Diabetic retinopathy: Early functional changes [J].
Alder, VA ;
Su, EN ;
Yu, DY ;
Cringle, SJ ;
Yu, PK .
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 1997, 24 (9-10) :785-788
[3]   Vascular permeability in experimental diabetes is associated with reduced endothelial occludin content - Vascular endothelial growth factor decreases occludin in retinal endothelial cells [J].
Antonetti, DA ;
Barber, AJ ;
Khin, S ;
Lieth, E ;
Tarbell, JM ;
Gardner, TW .
DIABETES, 1998, 47 (12) :1953-1959
[4]   Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes [J].
Chaturvedi, N ;
Sjolie, AK ;
Stephenson, JM ;
Abrahamian, H ;
Keipes, M ;
Castellarin, A ;
Rogulja-Pepeonik, Z ;
Fuller, JH .
LANCET, 1998, 351 (9095) :28-31
[5]   Upregulation of vascular endothelial growth factor by angiotensin II in rat heart endothelial cells [J].
Chua, CC ;
Hamdy, RC ;
Chua, BHL .
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH, 1998, 1401 (02) :187-194
[6]   Interleukin 6 induces the expression of vascular endothelial growth factor [J].
Cohen, T ;
Nahari, D ;
Cerem, LW ;
Neufeld, G ;
Levi, BZ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (02) :736-741
[7]  
CUBITT CL, 1995, INVEST OPHTH VIS SCI, V36, P330
[8]   RENIN, PRORENIN, AND IMMUNOREACTIVE RENIN IN VITREOUS FLUID FROM EYES WITH AND WITHOUT DIABETIC-RETINOPATHY [J].
DANSER, AHJ ;
VANDENDORPEL, MA ;
DEINUM, J ;
DERKX, FHM ;
FRANKEN, AAM ;
PEPERKAMP, E ;
DEJONG, PTVM ;
SCHALEKAMP, MADH .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1989, 68 (01) :160-167
[9]  
DANSER AHJ, 1994, INVEST OPHTH VIS SCI, V35, P1008
[10]   Pigment epithelium-derived factor: A potent inhibitor of angiogenesis [J].
Dawson, DW ;
Volpert, OV ;
Gillis, P ;
Crawford, SE ;
Xu, HJ ;
Benedict, W ;
Bouck, NP .
SCIENCE, 1999, 285 (5425) :245-248